Cleo Diagnostics Ltd (ASX:COV)
0.2750
+0.0050 (1.85%)
Nov 17, 2026, 10:23 AM AEDT
| Market Cap | 37.71M -44.6% |
| Revenue (ttm) | 1.72M +103.2% |
| Net Income | -5.94M |
| EPS | -0.04 |
| Shares Out | 137.11M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,004 |
| Open | 0.2750 |
| Previous Close | 0.2700 |
| Day's Range | 0.2750 - 0.2750 |
| 52-Week Range | 0.2600 - 0.9000 |
| Beta | 0.51 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 24, 2026 |